Information technologyTelehealth center breaks down barriers to healthcare | The Cavalier Daily
The University’s Karen S. Rheuban Center for Telehealth has saved Virginians over 16 million miles of travel in its more than two-decade history of combating disparities in the access and timeliness of healthcare.
PharmaceuticalsWill pharma use a tax break to create new jobs? That’s not what happened last time | STAT
Drug makers are promising to create tens of thousands of American jobs if President Donald Trump follows through on his promise to give them a big tax break if they “repatriate” cash they’ve stashed overseas. But that’s not what happened last time pharma got a tax holiday.
Vice President Mike Pence may have just picked another fight with pharmaceutical companies -- one that doesn’t involve drug prices. Pence is pushing for a nationwide law that would give terminally ill patients expanded access to experimental drugs that haven’t been approved yet but have made it through the first of three approval phases.
Dozens of new cancer drugs do little to improve survival, frustrating patients | Kaiser Health News
Pushed by patient advocates who want earlier access to medications, the¬ FDA has approved a flurry of oncology drugs in recent years, giving some people with cancer a renewed sense of hope and an array of expensive new options. Many drugs, however, have offered patients only marginal benefits, with no evidence that they improve survival or quality of life, said Dr. Vinay Prasad, assistant professor of medicine at the Oregon Health and Sciences University, who has written extensively about the FDA’s approval process for cancer drugs.
Safety, quality and clinical practiceFalse alarms delay future mammograms linked to later diagnosis | Reuters
Women who are told that their suspicious mammogram was a false alarm are more likely to delay their next scheduled mammogram, or possibly not show up for their next screening at all. The finding, in a study of 261,767 Chicago-area women in the journal Cancer Epidemiology, Biomarkers and Prevention, highlights an unintended consequence of such false alarms, known as false positives.